Baseline variables | Survival status, N = 416 | |||||
---|---|---|---|---|---|---|
Censored | DEAD | Total | ||||
N | % | N | % | N | ||
Sex (N = 416) | ||||||
Male | 190 | 48.00 | 10 | 50.00 | 200 | 48.10 |
Female | 206 | 52.00 | 10 | 50.00 | 216 | 51.90 |
Age at ART initiation (N = 416) | ||||||
≥120 months | 56 | 14.14 | 3 | 15.00 | 59 | 14.18 |
60-120 months | 140 | 35.35 | 4 | 20.00 | 144 | 34.62 |
36-59 months | 69 | 17.42 | 1 | 5.00 | 70 | 16.83 |
18-35 months | 73 | 18.43 | 4 | 20.00 | 77 | 18.51 |
<18 months | 58 | 14.65 | 8 | 40.00 | 66 | 15.87 |
Primary care giver (N = 402) | ||||||
Parents | 294 | 77.00 | 18 | 90.0 | 312 | 77.60 |
Relatives | 66 | 17.30 | 1 | 5.00 | 67 | 16.70 |
Guardians & Orphan | 22 | 5.80 | 1 | 5.00 | 23 | 5.70 |
Missing | 14 | 3.36 | ||||
TB at baseline (416) | ||||||
Yes | 112 | 28.30 | 15 | 75.00 | 127 | 30.53 |
No | 284 | 71.72 | 5 | 25.00 | 289 | 69.47 |
Baseline WHO clinical stage (N = 416) | ||||||
stage I & II | 93 | 23.50 | 1 | 5.0 | 94 | 22.60 |
stage III | 187 | 47.20 | 14 | 70.0 | 201 | 48.30 |
stage IV | 116 | 29.30 | 5 | 25.0 | 121 | 29.10 |
CD4 percentage (N = 412) | ||||||
≥10% | 223 | 56.89 | 6 | 30 | 229 | 55.58 |
<10% | 169 | 43.11 | 14 | 70 | 183 | 44.42 |
Hemoglobin level (N = 408) | ||||||
≥8 g/dl | 363 | 93.56 | 15 | 75 | 378 | 92.65 |
<8 g/dl | 25 | 6.44 | 5 | 25 | 30 | 7.35 |